POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

match.asia Launches Exit HealthCheck to Help SMEs Avoid Common M&A Deal Killers

In this episode of Global Economic Press, Alex Brady discusses the challenges faced by small and medium-sized enterprises in the realm of mergers and acquisitions. The focus is on a new initiative by match.asia, which aims to help these businesses navigate the complex landscape of business transactions. The episode highlights the launch of Exit HealthCheck, a free service designed to prevent common deal killers and enhance transaction success rates. By addressing issues such as misalignment between buyers and sellers, valuation gaps, and inadequate preparation for due diligence, match.asia seeks to improve the readiness of businesses before they enter the market. Match.asia, founded by experienced dealmakers, leverages its Match NAVI Artificial Intelligence ecosystem to provide practical solutions for improving transaction success rates. The company has built a rapidly growing proprietary dataset and network of verified sellers and accredited buyers across eight markets. With services like Match Value and Exit HealthCheck, match.asia aims to reduce valuation misunderstandings and help businesses prepare earlier for mergers and acquisitions. Business owners can evaluate their readiness for future transactions at no cost through Exit HealthCheck. For more information, visit match.asia [https://match.asia/].

Pimsy Just Went Live: The Digital Being Gen Z and Gen Alpha Already Follow

In this episode of Global Economic Press, Alex Brady delves into the innovative world of digital interaction with a focus on Pimsy, a digital being created by System Akvile. Designed to engage Generation Z and Generation Alpha, Pimsy offers a unique approach to skin health by providing relatable and revolutionary interactions. Unlike traditional chatbots, Pimsy has its own personality and perspective, making it a trusted companion for young audiences. System Akvile, led by Dr. Akvile Ignotaite, has crafted Pimsy to address the specific needs and behaviors of these generations, emphasizing accessibility and trust over commercialization. Pimsy stands out in a landscape where technology companies are increasingly giving their products human-like characters. However, Pimsy's approach is distinct; it does not sell or diagnose but instead guides users to professional help when necessary. This character-driven model has resonated with young people, as evidenced by Pimsy's growing following on TikTok. By prioritizing trust and understanding over technology, System Akvile has created a digital being that young people turn to for answers they might not seek elsewhere. For more information about System Akvile and Pimsy, visit their website at System Akvile [https://systemakvile.com].

POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding

In this episode of Global Economic Press, Alex Brady discusses a significant advancement in the biotechnology sector, focusing on POP Biotechnologies, a company based in Buffalo, New York. POP Biotechnologies has secured up to 9.7 million United States dollars in funding from the Coalition for Epidemic Preparedness Innovations to advance their innovative vaccine platform, known as SNAP (Spontaneous Nanoliposome Antigen Particle). This funding aims to support the development of a vaccine platform that uses protein-tagging technology in nanoparticles, which could accelerate the creation of vaccines against epidemic and pandemic threats such as the H5N1 avian influenza and potential future diseases. The SNAP platform is designed to enhance immune responses by improving antigen presentation, which could lead to more potent and targeted vaccine delivery. The Coalition for Epidemic Preparedness Innovations' investment builds on a previous award and supports the early clinical testing of a SNAP-based vaccine candidate targeting H5N1 avian influenza. This development aligns with the Coalition for Epidemic Preparedness Innovations' 100 Days Mission, a global effort to develop vaccines against new pandemic threats within 100 days of identification. POP Biotechnologies' SNAP technology offers a rapid and efficient approach to vaccine development, potentially improving manufacturing efficiency and extending vaccine supplies. The partnership between POP Biotechnologies and the Coalition for Epidemic Preparedness Innovations emphasizes equitable access to the outputs of their collaboration, with project results being published for the benefit of the global scientific community. For more information about POP Biotechnologies, visit their website at https://pop.bio [https://pop.bio].

Interentals Showcases Its Luxury Punta Mita Vacation Rentals on Emmy-Winning Apple TV Series Staycation

In this episode of Global Economic Press, Alex Brady delves into the luxury travel and hospitality sector, highlighting the impact of Interentals, a prominent vacation rental company, on the Emmy-winning television series Staycation. The episode explores how Interentals' luxury Punta Mita vacation rentals are showcased in a new 2026 episode of Staycation, which is available on platforms such as Apple TV, Tubi, and The Destination Channel. This feature builds on the company's previous Emmy win in 2025 and continues their collaboration with the series, offering viewers an in-depth look at the exquisite beachfront estates and personalized guest experiences that define Punta Mita as a premier luxury destination. The renewed feature on Staycation underscores Interentals' efforts to enhance the visibility of its luxury offerings in Mexico, particularly as travelers increasingly rely on online and artificial intelligence-powered searches for high-end accommodations. Beyond Punta Mita, Interentals' portfolio includes luxury rentals in Puerto Vallarta, Sayulita, and other locations along the Riviera Nayarit and Riviera Maya. Each property is complemented by the company's Signature Concierge Service, which provides personalized services such as private chefs and guided excursions. For more information on Interentals and its featured villas, visit their website at The Destination Channel [https://www.thedestinationchannel.com/].

Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany

In this episode of Global Economic Press, Alex Brady explores a significant advancement in medical tourism and personalized cancer treatment, focusing on a Canadian family's journey to Germany for innovative glioblastoma treatment. The episode highlights the potential of cross-border healthcare solutions, as Ron, a Canadian patient with grade 4 glioblastoma, found hope through dendritic cell therapy in Germany. This personalized immunotherapy option, not widely available in Canada, provided Ron with a new lease on life, showcasing the importance of international access to cutting-edge medical treatments. The podcast delves into the logistical and emotional challenges faced by Ron's family, emphasizing the role of Booking Health in facilitating their journey. Booking Health coordinated clinic placements, medical translations, and travel arrangements, allowing the family to focus on Ron's recovery. The episode underscores the differences in treatment access between Canada and Germany, highlighting the minimal side effects and tumor reduction achieved through dendritic cell therapy. For more information on Booking Health and their services, visit their website at https://bookinghealth.com/ [https://bookinghealth.com/].